Effects of Scapular Proprioceptive Neuromuscular Facilitation on Pain and Range of Motion in Patients With Adhesive Capsulitis
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Enrollment
- 32
- Locations
- 2
- Primary Endpoint
- Shoulder Pain
Study Overview
Brief Summary
The term ''frozen shoulder'' is defined as a clinical condition with restricted active and passive range of motion (ROM) in all directions, including flexion, abduction, and rotation.The objective of the study is to determine the effects of Scapular proprioceptive neuromuscular facilitation and conventional physical therapy among patients with adhesive capsulitis.The study will be a randomized controlled trial (single-blinded parallel study), consisting of 2 groups- interventional group A and interventional group B.Group A will be given conventional physical therapy and group B will be given conventional physical therapy alongwith scapular PNF.Scapular PNF exercises are not included in our routine PT treatment programs and there is limited literature related to the PNF techniques. These techniques help develop muscular strength and endurance, joint stability, mobility, neuromuscular control and coordination all of which are aimed at improving the overall functional ability of patients.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Outcomes Assessor)
Masking Description
The outcome assessor will not be aware of which group the participant belongs to.
Eligibility Criteria
- Ages
- 40 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Cases diagnosed with adhesive capsulitis, both primary and secondary origin.
- •Stage two and stage three of adhesive capsulitis.
- •Unilateral adhesive capsulitis.
- •Both males and females of the age group 40 years and above.
Exclusion Criteria
- •History of shoulder surgery or manipulation under anesthesia,
- •Local corticosteroid injection administration to the affected shoulder within the last 3 months.
- •Severe musculoskeletal, neurological and cardiovascular conditions.
Outcomes
Primary Outcomes
Shoulder Pain
Time Frame: 2 weeks
Shoulder Pain will be measured on the basis of visual analogue scale of 0-100mm. A higher score signifies greater pain.
Secondary Outcomes
- Shoulder range of motion (ROM)(2 weeks)
- Scapular mobility(2 weeks)